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AN INDIRECT ELISA TO DETECT THE SEROLOGIC RESPONSE OF
ELK (CERVUS ELAPHUS NELSONI ) INOCULATED WITH BRUCELLA
ABORTUS STRAIN RB51
Lesley A. Colby,1,4,5 Gerhardt G. Schurig,2 and Philip H. Elzer3

ABSTRACT: An indirect enzyme-linked immunosorbent assay (ELISA) was developed to identify
elk (Cervus elaphus nelsoni) with Brucella abortus strain RB51 (RB51)-specific antibodies using
a mouse monoclonal antibody specific for bovine IgG1. This test was relatively easy to perform,
accurate, and easily reproducible; therefore it could be standardized for use between laboratories.
In addition, we attempted to compensate for inherent variabilities encountered when comparing
ELISA readings from multiple samples taken from many animals over time. Optical density (OD)
readings for each sample were converted into a percent positivity value for analysis. A negative
cutoff value was determined above which a sample was considered to have a significantly elevated
anti-RB51 antibody level. Pre- and postvaccination sera from 64 6–8 mo old elk, divided into
four groups (females subcutaneously inoculated with saline (control animals), females ballistically
inoculated with RB51, females subcutaneously inoculated with RB51, and males subcutaneously
inoculated with RB51) were used. All serum samples were collected between 27 April and 15
November 1995. Values for all saline controls were appropriately below the negative cutoff value.
All subcutaneously and ballistically inoculated elk were serologically positive to RB51 for at least
two sampling periods during the study. The difference in percent positivity values for the ballistically compared to the subcutaneously inoculated groups was not statistically significant at 8, 10,
14, or 18 wk postvaccination. This suggests that processing RB51 into lactose based pellets and
ballistically inoculating elk with these pellets does not alter the detectable elk antibody response.
Also, inoculated and control animals can be accurately identified with ELISA at 4–8 weeks postvaccination.
Key words: Ballistic inoculation, Brucella abortus, Cervus elaphus nelsoni, ELISA, elk, serology, strain RB51.

INTRODUCTION

Brucella abortus is an aerobic, facultative intracellular, Gram negative bacteria
that causes disease in humans, domestic
animals, and wildlife. In cattle, B. abortus
infection may result in late term abortions,
births of nonviable calves, retained placentas, hygromas, and sterility (Cunningham,
1977). Currently, the US is attempting to
eradicate bovine brucellosis through a
combination of quarantine procedures, serologic tests, slaughter programs, and vaccination programs as directed by the Cooperative State-Federal Brucellosis Eradication Program (United States Department of Agriculture, 1998). While the US

has essentially eliminated brucellosis from
the livestock industry, many other countries report a high incidence of the disease
in both animal and human populations
(Boschiroli et al., 2001).
In the US, B. abortus has been isolated
from wildlife (Thorne et al., 1978; Tessaro,
1989) including bison (Bison bison) and
elk. Elk have the potential to transmit the
infection to cattle (Thorne et al., 1980).
Therefore, control or elimination of B.
abortus infection in wildlife has become a
high priority. One potential control measure involves vaccinating elk with B. abortus RB51 (RB51), a stable, rough mutant
of B. abortus strain 2308. Strain RB51 induces protection against challenge with
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MATERIALS AND METHODS
Animals

Sixty-four 6–8 mo old elk were captured
from the National Elk Refuge in Jackson Hole,
Wyoming (Teton County, Wyoming, USA:
43⬚30⬘N, 110⬚45⬘W) and housed at the Sybille
Wildlife Research and Conservation Education
Unit (Wyoming Game and Fish Department,
Wheatland, Wyoming). These elk are the same
elk studied in the published studies by Cook et
al. (2002) and Gall et al. (2001). Elk were held
in six pens. Both female and male elk were examined to eliminate gender bias. Saline inoculated elk served as a control group. The saline
controls were commingled with the RB51 vaccinated animals therefore serving as sentinels
and donors of negative control sera for the
ELISA. All animals were fed high quality alfalfa
hay and pellets. All elk were shown to be free
of Brucella infections by five consecutive negative reactions in the buffered Brucella antigen
(BBA), the standard plate agglutination (SPA),
rivanol (Riv), and the complement fixation tests
(CFT) (Alton et al., 1988). The elk were divided into four groups based on gender and route
of inoculation of viable RB51 organisms. Female, saline control animals received no RB51

organisms. Female, ballistically inoculated animals received between 2⫻107 and 3⫻108 organisms. Both female and male, subcutaneously inoculated animals received 1⫻109 organisms. The number of RB51 organisms administered to each group was retrospectively
determined through serial dilutions of each inoculum plated onto trypticase soy agar (Difco
Laboratories, Detroit, Michigan, USA).
Inocula were obtained from the National
Veterinary Services Laboratories (Ames, Iowa,
USA) of the Animal and Plant Health Inspection Service. Ballistic inocula were prepared in
biodegradable lactose-based pellets grown from
the same stock of RB51 used for subcutaneous
inoculation. Elk were bled 14 days prior to vaccination, at vaccination (day 0), and six times
after vaccination (weeks 4, 8, 10, 14, 18, and
27 postvaccination) from 27 April to 15 November 1995.
Blood was cultured for Brucella at the Wyoming Game and Fish Veterinary Diagnostic
Laboratory, University of Wyoming (Laramie,
Wyoming) for the first 4 mo of the experiment.
The hemoculture protocol followed that of Alton et al. (1988) as described in Cook et al.
(2002).
Bull elk were necropsied at bimonthly intervals after inoculation. One female elk (#38) was
injured during handling and was subsequently
euthanized.
RB51 whole cell antigen preparation

A lyophilized stock culture of RB51 was reconstituted with sterile trypticase soy broth.
Five hundred microliters of the broth solution
was spread on a trypticase soy agar (TSA) plate
and incubated for 48 hr at 37 C in a humidified
incubator supplemented with 5% CO2. Rough
morphology of the organisms was verified by
testing for agglutination in a 0.1% solution of
acriflavin in distilled water and by colony uptake of 0.05% crystal violet dye. After verification, the bacteria were subcultured on 10 TSA
plates and incubated for 72 hr (humidified 37
C chamber with 5% supplemental CO2). The
bacteria were harvested with 3–4 ml sterile distilled water, mixed with an equal volume of acetone, and stirred for 3 hr to kill the bacteria.
The bacteria were then washed three times
with sterile distilled water and pelleted by centrifugation at 6,000⫻G at 4 C for 10 min. Killed
bacteria were resuspended in sterile distilled
water to form a thick suspension and aliquoted
into sterile glass vials. The vials were frozen at
⫺70 C for 24 hr and lyophilized.
ELISA to detect anti-RB51 elk antibodies

Lyophilized RB51 was reconstituted in sterile distilled water to 5% transmittance at 525
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smooth virulent Brucella spp. in cattle
(Cheville et al., 1993), swine (Edmonds et
al., 2001), and mice (Jimenez de Bagues
et al., 1994). A major advantage of RB51
vaccination, regardless of the frequency,
dose, or route of inoculation, is its inability
to induce anti-LPS associated O-side chain
antibodies whose identification is the primary means of diagnosing field strain infections of Brucella spp (Stevens et al.,
1995). Protection against Brucella infection in cattle is believed to rely mainly on
cell mediated immunity; therefore antibody levels are not a predictor of immunity, but an indicator of exposure. A similar
situation is believed to be true in bison and
elk (Nicoletti and Winter, 1990).
This research was conducted to study
the serologic response of elk to vaccination
with RB51 and to develop an enzymelinked immunosorbent assay (ELISA) to
identify RB51 vaccinated elk. Both the
subcutaneous and ballistic vaccination
routes were evaluated because the ballistic
route may be a practical means of vaccinating wildlife (Herriges et al., 1989).
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incubated in the dark with 200 l of developing
solution at room temperature on a shaking platform (120 RPM) for 30 min. The developing
reaction in each well was stopped with 40 l of
0.18 M H2SO4. The optical density at 490 nm
was determined for each well with a 96-well
plate reader (Molecular Devices Corporation,
Sunnyvale, California, USA).
ELISA controls

Enzyme-linked immunosorbent assays were
designed to minimize the inter-well, inter-plate,
inter-animal, and time variability inherent in all
ELISAs. All serum sample dilutions were tested in duplicate wells to help assess inter-well
variability. Positive and negative control wells
were run in each plate. Wells coated with RB51
were incubated with a 1:100 dilution in PBST20 of a bovine serum with high anti-RB51 antibody levels (Steer 66) and were designated as
positive controls. The positive bovine serum
was obtained from a steer immunized repeatedly with RB51 at the Virginia-Maryland Regional College of Veterinary Medicine (Blacksburg, Virginia, USA). To create identical positive control samples, a large volume of the positive bovine serum was diluted 1:100 in
PBST-20, aliquoted, and frozen at ⫺70 C. A
new aliquot was thawed and used in each plate.
Three types of negative controls were run in
each plate. The first, ‘‘pre-inoculation serum
samples,’’ utilized two serum samples obtained
from each elk prior to inoculation with RB51
or saline. The second, ‘‘no antigen’’ wells, consisted of two wells for each serum sample (diluted 1:50) that were not coated with RB51 antigen stock solution. The third, ‘‘no serum’’
wells, consisted of two wells containing all appropriate reagents except serum. Two hundred
microliters of PBST-20 were used instead of
the diluted serum. Wells containing all appropriate reagents except conjugated antisera were
not tested on each plate because this combination had not been shown to cause nonspecific
binding in previous ELISAs (data not shown).
Calculation of percent positivity values

A percent positivity value was calculated for
all samples. Percent positivity is designed to
represent where a sample lies along a continuum with no binding of antibody being equivalent to 0% positivity and the antibody binding
of the positive control being equivalent to
100% positivity. Therefore, the percent positivity of each sample represents the ratio of RB51
specific antibody in that sample to the amount
of RB51 specific antibody in the positive control.
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nm to form an antigen stock solution which was
stored in polypropylene tubes at 4 C for no
longer than 1 wk. Immediately before use, this
stock solution was centrifuged (3 min at
11,800xG), the supernatant discarded, and the
original centrifuged volume of killed RB51 diluted 1:20 (v/v) in bicarbonate phosphate buffer (pH 9.6) generating the antigen working solution. Appropriate wells of 96 well mediumbinding polystyrene plates (Costar Corporation,
Kennebunk, Maine, USA) were coated with
200 l of antigen working solution, the plates
sealed with a parafilm sheet, and the plate incubated in a humidified chamber at 4 C overnight.
The plates were allowed to equilibrate to
room temperature in a dark, humidified chamber and were washed four times with freshly
prepared phosphate buffered solution containing 0.05% Tween 20 (PBST-20) using a semiautomated plate washer (NUNC Immunowash,
Naperville, Illinois, USA). For each washing,
wells were filled with approximately 250 l of
PBST-20, allowed to soak for approximately 20
sec, and then emptied by suction. After the
fourth washing, the plates were inverted and
tapped on a countertop to fully remove the
washing buffer from the wells. However, the
wells were never allowed to completely dry because this can cause high non-specific binding
(Nielsen et al., 1996). Serum samples were diluted 1:50 in PBST-20 in a 96-well polypropylene plate immediately before dispensing into
the antigen-coated wells. Many other serum dilutions were evaluated in previous trials (data
not shown) which indicated that the 1:50 (v/v)
serum dilution was optimal for this ELISA.
Two hundred microliters of each diluted serum
sample were then incubated in the RB51-coated polystyrene plates at 37 C for 30 min. All
incubations in future steps were also performed
at 37 C. After incubation, the wells were
washed four times. Each well was then incubated with 200 l of a 1:6,000 (v/v) dilution of
mouse monoclonal anti-bovine IgG1 (Veterinary Medical Research and Development,
BIg715A, Pullman, Washington, USA) in
PBST-20 for 30 min. Next, the plates were
washed four times and then incubated for 30
min with 200 l of polyclonal horseradish-peroxidase-conjugated goat IgG fraction to mouse
IgG whole molecule (Cappel Laboratories,
West Chester, Pennsylvania, USA) diluted 1:
800 (v/v) in PBST-20. The plates were washed
four times. A developing solution was prepared
immediately before use by mixing 10 mg of ortho-phenylenediamine (Sigma, St. Louis, Missouri, USA) in 1 ml of 100% methanol and adding it to freshly prepared 100 ml distilled water
containing 100 l of 30% H2O2. The wells were
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The percent positivity of each sample was
calculated with the following equation:
%positivity
⫽ 100 ⫻ [specific OD of the test serum
⫼ specific OD of the positive
control]
where:
specific OD of test serum
⫽ [(test sample OD)
⫺ (average OD of all pre-inoculation
samples from that elk)]
and:
specific OD of positive control
⫽ [(positive control serum OD)
⫺ (no serum sample OD)]
Non-specific binding for each animal serum
was partially corrected for by calculating the
specific optical density for each animal’s sample. Because no ’prevaccination’ sample was
available for the positive control sample (Steer
66), non-specific binding of the sera was approximated by subtracting the OD of a well
that contained all reagents except serum from
the OD of the positive control.
A negative cut-off value was determined by
computing the average plus three standard deviations of the percent positivity values of all
saline elk samples as described in the following
equation:

FIGURE 2. Percent positivity of serum samples
(diluted 1:50) obtained from all ballistically inoculated elk. The horizontal dashed line corresponds to the
negative cutoff value of 2.1 percent positivity.

ue above this cutoff was considered to have a
significant antibody response in this test.
RESULTS

Using the previously defined equation,
a negative cutoff value of 2.1 percent positivity was calculated. Therefore, all samples with a percent positivity ⬎2.1 were
classified as having a significant anti-RB51
antibody response while samples with a
percent positivity ⱕ2.1 were considered to
not have a significant anti-RB51 antibody
response.
All samples from each saline inoculated
elk were below the negative cutoff value
and samples from at least two time periods
during the study for all RB51 inoculated
elk were above the cutoff. Figures 1–4 are

negative cutoff value
⫽ [average percent positivity
value of all saline inoculated samples]
⫹ [3(standard deviation of the percent
positivity of all saline inoculated
samples)]
Any serum sample with a percent positivity val-

FIGURE 3. Percent positivity of serum samples
(diluted 1:50) obtained from all female subcutaneously inoculated elk. The horizontal dashed line corresponds to the negative cutoff value of 2.1 percent
positivity.

Downloaded from http://meridian.allenpress.com/doi/pdf/10.7589/0090-3558-38.4.752 by Louisiana State University - Baton Rouge user on 18 January 2022

FIGURE 1. Percent positivity of serum samples
(diluted 1:50) obtained from all saline inoculated elk.
The horizontal dashed line corresponds to the negative cutoff value of 2.1 percent positivity.
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graphs of the percent positivity of each
elk’s serum samples within their respective
groups. More detailed results may be
found in Colby (1997).
DISCUSSION

Mouse monoclonal bovine IgG1 antiserum was chosen for use in the ELISA
based upon Henning and Nielsen (1992)
finding 100% cross-reactivity between elk
and bovine IgG1 as well as the finding that
field strain Brucella infections cause a
large IgG1 antibody response. Because this
anti-sera only identifies antibodies of the
IgG1 sub-isotype it is not a true representation of the overall antibody response.
However, it does fulfill the objective of developing an ELISA to identify RB51 vaccinated elk through serology. Other antiisotypes may be equally effective for use
in the ELISA. However, anti-bovine isotypes other than anti-IgG1 do not show
100% cross- reactivity with elk isotypes
and no horseradish-peroxidase-conjugated
anti-elk isotypes are currently commercially available.
Many methods for interpreting ELISA
data have been described (Heck et al.,
1980; Gall and Nielsen, 1994; Nielsen et
al. 1996). Most methods have major limitations as they do not compensate for multi-animal, inter-well, or inter-plate variability. Also, many systems require the re-

Downloaded from http://meridian.allenpress.com/doi/pdf/10.7589/0090-3558-38.4.752 by Louisiana State University - Baton Rouge user on 18 January 2022

FIGURE 4. Percent positivity of serum samples
(diluted 1:50) obtained from all bull subcutaneously
inoculated elk. The horizontal dashed line corresponds to the negative cutoff value of 2.1 percent
positivity.

searcher to assign an arbitrary value above
which a sample would be considered positive. This value often has no statistical validity. The analysis of data obtained with
the ELISA developed in this study considered these variabilities. This ELISA is an
accurate and easily reproducible method
to identify elk with RB51 specific antibody
titers.
Numerous controls were utilized in the
ELISA. Non-specific binding of antibodies
to the polystyrene plate or the RB51 antigen was evaluated in wells containing either no elk serum or no antigen coating.
Duplicates of serum samples obtained prior to vaccination (14 days prior to and on
the day of vaccination) were assumed to
contain no specific antibodies to RB51 because the animals had not been vaccinated
with any rough Brucella organisms and
were shown to be free of exposure to
smooth Brucella organisms. These prevaccination serum samples were used as negative controls for each animal in each
plate. The magnitude and variability of the
optical density value obtained with these
samples was assumed to represent the normal ‘background’ value for the animals.
Because no test had previously been developed to assess the level of anti-RB51
antibodies in elk serum, an elk serum of
known antibody level was not available. As
a result, bovine serum (Steer 66) with a
high concentration of specific anti-RB51
antibodies was used as the positive control
in each plate. In the future, hyper-immune
elk sera or monoclonal anti-RB51 antibodies should be produced and used as positive control sera. The ELISA could then
be standardized across multiple laboratories thereby allowing comparison of samples across laboratories.
Because the saline and the RB51 vaccinated groups belong to the same population, the saline calculated cutoff value
should correctly identify ⬎99.5% of all truly negative samples within the RB51 vaccinated groups. Using this rationale, all
RB51 inoculated elk had an antibody response to vaccination with RB51. Al-
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the antibody response of elk to RB51.
While developing this ELISA, we also examined the use of dot blot assays (Colby
1997). However, in our hands, dot blot assays were labor intensive because they did
not lend themselves to automation. We
also found interpretation of dot blot assay
results to be hard to evaluate and very subjective. Repetitions of identical dot blots
resulted in variable intensity of color development and due to their variability,
samples could not be compared across
multiple dot blots. In our hands, using a
computer image analysis program (NIH
Image, US National Institutes of Health)
did not resolve the evaluation problems
(Colby, 1997). Alternatively, ELISAs can
be easily automated and objectively evaluated. Through the use of percent positivity values and standardized reagents, they
allow the comparison of samples across
multiple laboratories.
Our indirect ELISA is relatively easy to
perform, is suitable to automation and
standardization across multiple laboratories, and correctly identifies RB51 inoculated animals. Although the current RB51
vaccine may not provide elk with adequate
protection against infection with Brucella,
multiple genetically modified RB51 organisms are currently being developed (Vemulapalli et al., 2000a, b) and will likely
be evaluated for use in elk. This ELISA
could be used to monitor the antibody response of elk to vaccination with genetically modified RB51 organisms as well as
other rough Brucella organisms.
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